An omission to the funding section of the original article was made in error. The following sentence has been added: “Open access funding was provided by the University of Lausanne.”
The original article has been updated.
. 2023 Mar 22;10:1183711. doi: 10.3389/fmed.2023.1183711
Erratum: Overview of the RGD-based PET agents use in patients with cardiovascular diseases: A systematic review
Frontiers Production Office1,*
1Frontiers Media SA, Lausanne, Switzerland
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Production Office production.office@frontiersin.org
This article was submitted to Nuclear Medicine, a section of the journal Frontiers in Medicine
Received 2023 Mar 10; Accepted 2023 Mar 10; Collection date 2023.
Keywords: αvβ3 integrin, RGD, angiogenesis, positron emission tomography, cardiovascular diseases, myocardial infarction, atherosclerosis
Copyright © 2023 Frontiers Production Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC10074711 PMID: 37035325
This corrects the article "Overview of the RGD-Based PET Agents Use in Patients With Cardiovascular Diseases: A Systematic Review" in volume 9, 887508.